Obesity and renal hemodynamics

Contributions to Nephrology

Volumn 151, Issue , 2006, Pages 184-202

  Bosma, R J ^a   Krikken, J A ^a   Homan Van Der Heide, J J ^a   De Jong, P E ^a   Navis, G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HUMAN; KIDNEY CIRCULATION; KIDNEY DISEASE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

ANIMALS; HUMANS; KIDNEY DISEASES; OBESITY; RENAL CIRCULATION; RISK FACTORS;

EID: 33748079482     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095329     Document Type: Review

References (104)

1. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, et al: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001;37:720-727.
2. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822.
3. Kasiske BL, Napier J: Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985;5:45-50.
4. de Vries AP, Bakker SJ, van Son WJ, van der Heide JJ, Ploeg RJ, The HT, et al: Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004;4:1675-1683.
5. el Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA: Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004;77:1381-1385.
6. Halme L, Eklund B, Kyllonen L, Salmela K: Is obesity still a risk factor in renal transplantation? Transpl Int 1997;10:284-288.
7. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B: The effect of body mass index on long-term renal allograft survival. Transplantation 1999;68:1294-1297.
8. Meier-Kriesche HU, Arndorfer JA, Kaplan B: The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73:70-74.
9. Mitsnefes MM, Khoury P, McEnery PT: Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 2002;17:535-539.
10. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-655.
11. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.
12. Yoshida Y, Fogo A, Shiraga H, Glick AD, Ichikawa I: Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int 1988;33:855-867.
13. Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Glick AD, Deen WM, et al: 'Intact nephrons' as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest 1988;82:1614-1623.
14. Hall RL, Wilke WL, Fettman MJ: Captopril slows the progression of chronic renal disease in partially nephrectomized rats. Toxicol Appl Pharmacol 1985;80:517-526.
15. Park SK, Kang SK: Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med 1995;10:48-53.
16. Schmitz PG, O'Donnell MP, Kasiske BL, Katz SA, Keane WF: Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 1992;263 (pt 2):F496-F502.
17. Apperloo AJ, de Zeeuw D, de Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997;51:793-797.
18. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 1995;47:1726-1731.
19. Agarwal R, Nicar MJ: A comparative analysis of formulas to predict creatinine clearance (abstract). J Am Soc Nephrol 1994;5:386.
20. Baracskay D, Jarjoura D, Cugino A, Blend D, Rutecki GW, Whittier FC: Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population. Clin Nephrol 1997;47:222-228.
21. Bjornsson TD: Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 1979;4:200-222.
22. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
23. Edwards KDG, Whyte HM: Plasma creatinine level and creatinine clearance as tests of renal function. Aust Ann Med 1959;8:218-224.
24. Gates GF: Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function. Am J Kidney Dis 1985;5:199-205.
25. Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM: Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981;29:516-521.
26. Jelliffe RW: Estimation of creatinine clearance when urine cannot be collected. Lancet 1971;1:975-976.
27. Jelliffe RW: Letter: Creatinine clearance: bedside estimate. Ann Intern Med 1973;79:604-605.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
29. Mawer GE, Lucas SB, Knowles BR, Stirland RM: Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet 1972;1:12-15.
30. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR: Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995;59:1683-1689.
31. Nankivell BJ, Chapman JR, Allen RD: Predicting glomerular filtration rate after simultaneous pancreas and kidney transplantation. Clin Transplant 1995;9:129-134.
32. Nguyen HT, Shannon AG, Coates PA, Owens DR: Estimation of glomerular filtration rate in type II (non-insulin dependent) diabetes mellitus patients. IMA J Math Appl Med Biol 1997;14:151-160.
33. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, et al: Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004;43:112-119.
34. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988;84:1053-1060.
35. Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, et al: Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J Am Soc Nephrol 1997;8:279-287.
36. Walser M, Drew HH, Guldan JL: Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 1993;44:1145-1148.
37. Bosma RJ, Doorenbos CR, Stegeman CA, van der Heide JJ, Navis G: Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am J Transplant 2005;5:2193-2203.
38. Cirillo M, Anastasio P, De Santo NG: Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 2005;20:1791-1798.
39. Schmieder RE, Beil AH, Weihprecht H, Messerli FH: How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol 1995;5:1709-1713.
40. Anastasio P, Spitali L, Frangiosa A, Molino D, Stellato D, Cirillo E, et al: Glomerular filtration rate in severely overweight normotensive humans. Am J Kidney Dis 2000;35:1144-1148.
41. Ribstein J, du CG, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 1995;26:610-615.
42. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985;106:598-604.
43. O'Donnell MP, Kasiske BL, Cleary MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med 1985;106:605-610.
44. Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001;14(pt 2):103S-115S.
45. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486.
46. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, et al: Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 1995;19:403-409.
47. van Paassen P, de Zeeuw D, Navis G, de Jong PE: Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? Hypertension 1996;27:202-208.
48. Porter LE, Hollenberg NK: Obesity, salt intake, and renal perfusion in healthy humans. Hypertension 1998;32:144-148.
49. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G: Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004;65:259-265.
50. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-285.
51. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E: Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-1204.
52. Bosma RJ, Kwakernaak AJ, Homan van der Heide JJ, Jong de PE, Navis G: Does a high body mass index induce glomerular hyperfiltration in renal transplant patients? Am J Transplant 2006.
53. Srivastava T: Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006;21:463-470.
54. Praga M, Hernandez E, Morales E, Campos AP, Valero MA, Martinez MA, et al: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:1790-1798.
55. Landsberg L, Krieger DR: Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989;2(pt 2):125S-132S.
56. ter Maaten JC, Bakker SJ, Serne EH, ter Wee PM, Donker AJ, Gans RO: Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant 1999;14:2357-2363.
57. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996;28:127-132.
58. Landsberg L: Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A 1990;12:817-830.
59. Minaker KL, Rowe JW, Tonino R, Pallotta JA: Influence of age on clearance of insulin in man. Diabetes 1982;31:851-855.
60. Welle S, Lilavivathana U, Campbell RG: Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. Metabolism 1980;29:806-809.
61. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-225.
62. Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA: Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol 1991;260(pt 2):F663-F669.
63. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC: Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 1992;42:1160-1168.
64. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003;41:733-741.
65. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-1217.
66. Engeli S, Sharma AM: Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res 2000;32:485-499.
67. Ailhaud G, Fukamizu A, Massiera F, Negrel R, Saint-Marc P, Teboul M: Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes Relat Metab Disord 2000;24 (suppl 4):S33-S35.
68. Pratt JH, Ambrosius WT, Tewksbury DA, Wagner MA, Zhou L, Hanna MP: Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. Hypertension 1998;32:875-879.
69. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al: Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997;95:2348-2350.
70. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM: Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998;16:1475-1480.
71. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005;45:356-362.
72. Ruano M, Silvestre V, Castro R, Garcia-Lescun MC, Rodriguez A, Marco A, et al: Morbid obesity, hypertensive disease and the renin-angiotensin- aldosterone axis. Obes Surg 2005;15:670-676.
73. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J, et al: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996;14:199-207.
74. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, Hillen H, et al: Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 2000;35(pt 2):329-336.
75. Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK: Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005;46:1316-1320.
76. Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK: Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabetes Med 2002;19:858-861.
77. Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL: Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995;70:35-41.
78. Schnermann J, Briggs JP: The macula densa is worth its salt. J Clin Invest 1999;104:1007-1009.
79. Hall JE: The kidney, hypertension, and obesity. Hypertension 2003;41(pt 2):625-633.
80. Kikuchi K, Iimura O, Yamaji I, Shibata S, Nishimura M, Aoki K, et al: The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension. Am J Hypertens 1988;1:31-37.
81. Waki M, Kral JG, Mazariegos M, Wang J, Pierson RN Jr, Heymsfield SB: Relative expansion of extracellular fluid in obese vs. nonobese women. Am J Physiol 1991;261(pt 1):E199-E203.
82. Hall JE, Brands MW, Dixon WN, Smith MJ Jr: Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993;22:292-299.
83. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, et al: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989;321:580-585.
84. Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK: Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005;46:1316-1320.
85. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE: Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 1996;28:1047-1054.
86. Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, et al: Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004;11:41-54.
87. Wofford MR, Hall JE: Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004;10:3621-3637.
88. Quinones-Galvan A, Ferrannini E: Renal effects of insulin in man. J Nephrol 1997;10:188-191.
89. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L: Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 2003;12:195-200.
90. Aviv A, Hollenberg NK, Weder AB: Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. Kidney Int 2004;65:361-368.
91. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991;18:805-812.
92. Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M: Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension 2000;36:631-637.
93. Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH: Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med 1986;81:412-418.
94. Hollenberg NK: Sodium and the kidney: the non-modulator concept. Nephrol Dial Transplant 2001;16(suppl 6):38-39.
95. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994;23:195-199.
96. Rahmouni K, Haynes G: Leptin and the central neural mechanisms of obesity hypertension. Drugs Today (Barc) 2002;38:807-817.
97. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M: Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997;96:3423-3429.
98. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG: Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005;54:2012-2018.
99. Beltowski J, Jochem J, Wojcicka G, Zwirska-Korczala K: Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Regul Pept 2004;120:59-67.
100. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-655.
101. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:1498-1509.
102. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL: Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002;26(suppl 4):S21-S24.
103. Boyd ST, Fremming BA: Update on rimonabant - a selective cannabinoid CB1 antagonist (May). Ann Pharmacother 2006;40:994.
104. Reisin E, Messerli FG, Ventura HO, Frohlich ED: Renal haemodynamic studies in obesity hypertension. J Hypertens 1987;5:397-400.